Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Dabigatran market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Dabigatranmarket, defines the market attractiveness level of Dabigatran market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Dabigatran industry, describes the types of Dabigatran market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dabigatran market and the development prospects and opportunities of Dabigatran industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dabigatran market in Chapter 13.
By Player:
Aspen Holdings
Bristol-Myers Squibb Company
GlaxoSmithKline
Bayer Healthcare
Teva Pharmaceutical Industries
Pfizer
Boehringer Ingelheim
By Type:
Tablets
Capsule
Others
By End-User:
Deep vein thrombosis
Pulmonary embolism
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Dabigatran Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Dabigatran Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Dabigatran Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Dabigatran Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Dabigatran Market Analysis and Outlook to 2022
-
7.1 Global Dabigatran Consumption (2017-2022)
-
7.2 United States Dabigatran Consumption (2017-2022)
-
7.3 Europe Dabigatran Consumption (2017-2022)
-
7.4 China Dabigatran Consumption (2017-2022)
-
7.5 Japan Dabigatran Consumption (2017-2022)
-
7.6 India Dabigatran Consumption (2017-2022)
-
7.7 South Korea Dabigatran Consumption (2017-2022)
8 Region and Country-wise Dabigatran Market Analysis and Outlook to 2028
-
8.1 Global Dabigatran Consumption Forecast (2022-2028)
-
8.2 United States Dabigatran Consumption Forecast (2022-2028)
-
8.3 Europe Dabigatran Consumption Forecast (2022-2028)
-
8.4 China Dabigatran Consumption Forecast (2022-2028)
-
8.5 Japan Dabigatran Consumption Forecast (2022-2028)
-
8.6 India Dabigatran Consumption Forecast (2022-2028)
-
8.7 South Korea Dabigatran Consumption Forecast (2022-2028)
9 Global Dabigatran Market Outlook by Types and Applications to 2022
-
9.1 Global Dabigatran Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Dabigatran Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Deep vein thrombosis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pulmonary embolism Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Dabigatran Market Outlook by Types and Applications to 2028
-
10.1 Global Dabigatran Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Dabigatran Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Deep vein thrombosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pulmonary embolism Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Dabigatran Import and Export Analysis (Top 5 Countries)
-
11.1 Global Dabigatran Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Dabigatran Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Dabigatran Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Dabigatran Market Competitive Analysis
-
14.1 Aspen Holdings
-
14.1.1 Aspen Holdings Company Details
-
14.1.2 Aspen Holdings Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Aspen Holdings Dabigatran Product and Service
-
14.2 Bristol-Myers Squibb Company
-
14.2.1 Bristol-Myers Squibb Company Company Details
-
14.2.2 Bristol-Myers Squibb Company Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Company Dabigatran Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Dabigatran Product and Service
-
14.4 Bayer Healthcare
-
14.4.1 Bayer Healthcare Company Details
-
14.4.2 Bayer Healthcare Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer Healthcare Dabigatran Product and Service
-
14.5 Teva Pharmaceutical Industries
-
14.5.1 Teva Pharmaceutical Industries Company Details
-
14.5.2 Teva Pharmaceutical Industries Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Pharmaceutical Industries Dabigatran Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Dabigatran Product and Service
-
14.7 Boehringer Ingelheim
-
14.7.1 Boehringer Ingelheim Company Details
-
14.7.2 Boehringer Ingelheim Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Boehringer Ingelheim Dabigatran Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Dabigatran
-
Figure Dabigatran Picture
-
Table Global Dabigatran Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dabigatran Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dabigatran Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Dabigatran Consumption by Country (2017-2022)
-
Figure United States Dabigatran Consumption and Growth Rate (2017-2022)
-
Table Europe Dabigatran Consumption and Growth Rate (2017-2022)
-
Figure China Dabigatran Consumption and Growth Rate (2017-2022)
-
Figure Japan Dabigatran Consumption and Growth Rate (2017-2022)
-
Figure India Dabigatran Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dabigatran Consumption and Growth Rate (2017-2022)
-
Figure Global Dabigatran Consumption Forecast by Country (2022-2028)
-
Figure United States Dabigatran Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dabigatran Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Dabigatran Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dabigatran Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dabigatran Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dabigatran Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Deep vein thrombosis Consumption and Growth Rate (2017-2022)
-
Figure Global Pulmonary embolism Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Deep vein thrombosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pulmonary embolism Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Dabigatran Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Dabigatran Export by Region (Top 5 Countries) (2017-2028)
-
Table Aspen Holdings (Foundation Year, Company Profile and etc.)
-
Table Aspen Holdings Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Holdings Dabigatran Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Dabigatran Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Dabigatran Product and Service
-
Table Bayer Healthcare (Foundation Year, Company Profile and etc.)
-
Table Bayer Healthcare Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Dabigatran Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Dabigatran Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Dabigatran Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Dabigatran Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Dabigatran Product and Service
-
